Type 2 diabetes mellitus in children and adolescents

Journal of Endocrinological Investigation

Volumn 28, Issue 11, 2005, Pages 853-863

  Marcovecchio, M ^a   Mohn, A ^a   Chiarelli, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adolescents; Children; Insulin resistance; T2DM; Youth

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEGLITINIDE; METFORMIN; PLACEBO; RESIN; SULFONYLUREA;

ACANTHOSIS NIGRICANS; CLINICAL TRIAL; COMORBIDITY; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ETHNOLOGY; FAMILY HISTORY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREVALENCE; PUBERTY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYNDROME X;

EID: 31544463271     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03347581     Document Type: Review

References (79)

1. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000, 23: 381-9.
2. Deckelbaum RJ, Williams CL. Childhood obesity: The health issue. Obes Res 2001, 9 (Suppl 4): 239-43.
3. Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ. Increasing prevalence of Type II diabetes in American Indian children. Diabetologia 1998, 41: 904-10.
4. Freedman DS, Serdula MK, Percy CA, Ballew C, White L. Obesity, levels of lipids and glucose, and smoking among Navajo adolescents. J Nutr 1997, 127 (Suppl 10): 2120-7.
5. Dean HJ, Young TK, Flett B, Wood-Steiman P. Screening of type 2 diabetes in aboriginal children in northern Canada. Lancet 1998, 352: 1523-4.
6. Acton KJ, Burrows NR, Moore K, Querec L, Geiss LS, Engelgau MM. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health 2002, 92: 1485-90.
7. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996, 128: 608-15.
8. Willi SM, Kennedy A, Wojciechowski B, et al. Insulin resistance and defective glucose-insulin coupling in ketosis-prone type 2 diabetes of African-American Youth. Diabetes 1998, 47 (Suppl 1): 306 (abstract).
9. Hale DE, Danney KM. Non-insulin dependent diabetes in Hispanic youth (type 2Y). Diabetes 1998, 47 (Suppl 1): 82 (abstract).
10. Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am 1997, 44: 307-37.
11. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 2000, 13 (Suppl 6): 1395-402.
12. Kitagawa T, Owada M, Urakami T, Yamauchi K. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin Pediatr (Phila) 1998, 37: 111-5.
13. Kadiki OA, Reddy MR, Marzouk AA. Incidence of insulin-dependent diabetes (IDDM) and non-insulin dependent diabetes (NIDDM) (0-34 years at onset) in Benghazi, Libya. Diabetes Res Clin Pract 1996, 32: 165-73.
14. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG, for the British Society for Paediatric Endocrinology and Diabetes Clinical Trials Group. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004, 89: 526-9.
15. Ehtisham S, Kirk J, McEvilly A, Shaw N, et al. Prevalence of type 2 diabetes in children in Birmingham. BMJ 2001, 322: 1428.
16. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity - a problem that is no longer restricted to minority groups. Eur J Endocrinol 2004, 151: 199-206.
17. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997, 14(Suppl 5): 1-85.
18. Arslanian S. Type 2 diabetes mellitus in children: pathophysiology and risk factors. J Pediatr Endocrinol Metab 2000, 13 (Suppl 6): 1385-94.
19. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346: 802-10.
20. Liu L, Hironaka K, Pihoker C. Type 2 diabetes in youth. Curr Probl Pediatr Adolesc Health Care 2004, 34: 254-72.
21. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology-from West to the rest. Diabetes Care 1992, 15: 232-52.
22. Arslanian S. Type 2 diabetes mellitus in children: clinical aspects and risk factors. Horm Res 2002, 57 (Suppl 1): 19-28.
23. Rossetti L. Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. Clin Invest Med 1995, 18: 255-60.
24. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003, 88: 1417-27.
25. Ludwig DS, Ebbeling CB. Type 2 diabetes mellitus in children. Primary care and public health considerations. JAMA 2001, 286: 1427-30.
26. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994, 43: 1066-84.
27. Elbein SC, Hoffman MD, Bragg KL, Mayorga RA. The genetics of NIDDM. An update. Diabetes Care 1994, 17: 1523-33.
28. McIntyre EA, Walker M. Genetics of type 2 diabetes and insulin resistance: knowledge from human studies. Clin Endocrinol (Oxf) 2002, 57: 303-11.
29. Kiess W, Bottner A, Raile K, et al. Type 2 diabetes mellitus in children and adolescents: a review from a European perspective. Horm Res 2003, 59 (Suppl 1): 77-84.
30. Phillips DI. Birth weight and the future development of diabetes. A review of the evidence. Diabetes Care 1998, 21 (Suppl 2):150-5.
31. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH, Knowler WC. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care 1999, 22: 944-50.
32. Arslanian S, Suprasongin C. Insulin sensitivity, lipids and body composition in children: is "syndrome X" present? J Clin Endocrinol Metab 1996, 81: 1058-62.
33. Rocchini AP. Childhood obesity and diabetes epidemic. N Engl J Med 2002, 346: 854-5.
34. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996, 39: 1489-97.
35. Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood. Endocrinol Metab Clin North Am 1999, 28: 731-47.
36. Caprio S, Hyman LD, Limb C, et al. Central adiposity and its metabolic correlates in obese adolescents girls. Am J Physiol 1995, 269: E118-26.
37. Weil J, Vanderbecken S, Froguel P. Understanding the rising incidence of type 2 diabetes in adolescence. Arch Dis Child 2004, 89: 502-5.
38. Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker D. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004, 350: 865-75.
39. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999, 22: 345-54.
40. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990, 6: 1-27.
41. Danadian K, Balasekaran G, Lewy V, Meza M, Robertson R, Arslanian SA. Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care 1999, 22: 1325-9.
42. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler PS. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999, 153: 1063-7.
43. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000, 136: 664-72.
44. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS. Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study. Diabetes 1992, 41: 313-7.
45. Ong KL, Dunger DB. Thrifty genotypes and phenotypes in the pathogenesis of type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2000, 13: 1419-24.
46. Smith CP, Dunger DB, Williams AJ, et al. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty and adult life. J Clin Endocrinol Metab 1989, 68: 932-7.
47. Smith CP, Williams AJ, Thomas DM, et al. The pattern of basal and stimulated insulin responses to intravenous glucose in first degree relatives of type 1 (insulin-dependent) diabetic children and unrelated adults aged 5 to 50 years. Diabetologia 1988, 31: 430-4.
48. Hindmarsh P, Di Silvio L, Pringle PJ, Kurtz AB, Brook CG. Changes in serum insulin concentration during puberty and their relationship to growth hormone. Clin Endocrinol (Oxf) 1988, 28: 381-8.
49. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986, 315: 215-9.
50. Caprio S, Plewe G, Diamond MP, et al. Increased insulin secretion in puberty: a compensatory response to reduction in insulin sensitivity. J Pediatr 1989, 114: 963-7.
51. Arslanian SA, Danadian K, Suprasongin C. GH treatment in adolescents with non-GH deficient short stature (NGHD-SS): physical, biochemical and metabolic changes. Pediatr Res 1999, 45: 84 (abstract).
52. Arslanian SA, Danadian K. Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. J Clin Endocrinol Metab 1997, 82: 3213-20.
53. Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001, 86: 66-71.
54. Lewy V, Danadian K, Witchel SF, Arslanian SA. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 2001, 138: 38-44.
55. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83: 3078-82.
56. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emaus SS, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 1017-23.
57. Arslanian SA, Lewy V, Danadian K, et al. Metformin therapy in obese adolescents with PCOS and impaired glucose tolerance: amelioration of exaggerated adrenal response to ACTH with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002, 87: 1055-9.
58. Banerjee S, Raghavan S, Wasserman EJ, Linder BL, Saenger P, Di Martino-Nardi J. Hormonal finding in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Pediatrics 1998, 102: E36.
59. Ibanez L, Potau N, Marcos MV, de Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999, 84: 4739-41.
60. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med 2004, 351: 2179-86.
61. Dabelea D, Knowler WC, Pettitt DJ. Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med 2000, 9: 83-8.
62. Silverman BL, Metzker BE, Cho NH, Loeb CA. Fetal hyperinsulinism and impaired glucose tolerance in adolescent offspring of diabetic mothers. Diabetes Care 1995, 18: 611-7.
63. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silnk M, for the Consensus Workshop Group. Type 2 diabetes in the youth: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004, 27: 1798-811.
64. Ritchie LD, Ganapathy S, Woodward-Lopez G, Gerstein D, Fleming SE. Prevention of type 2 diabetes in youth: etiology, promising interventions and recommendations. Pediatr Diabetes 2003, 4: 174-209.
65. Cook V, Hurley J. Prevention of type 2 diabetes in childhood. Clin Pediatr (Phila) 1998, 37: 123-30.
66. Norgren S, Danielsson P, Jurold R, Lotborn M, Marcus C. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr 2003, 92: 666-70.
67. Monzavi R, Dreimane D, Geffuer M, et al. Improvements in metabolic syndrome and insulin resistance in obese youth treated with lifestyle intervention. Diabetes 2004, 53: (Suppl 2): 7 (abstract).
68. Pilot feasibility study group of the studies to treat or prevent type 2 diabetes (STOPP-T2D) collaborative group. Obesity, diabetes and the metabolic syndrome in 8th grade children. Diabetes 2004, 53 (suppl 2): 7 (abstract).
69. American Diabetes Association. Clinical Practice Recommendations. Diabetes Care 1999, 22 (Suppl): 1-114.
70. Rosenbloom AL. Increasing incidence of type 2 diabetes in children and adolescents: treatment consideration. Pediatr Drugs 2002, 4: 209-21.
71. Silverstein JH, Rosenbloom AL. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metabol 2000, 13: 1403-9.
72. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003, 26 (Suppl 1): 51-61.
73. Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk for type 2 diabetes in women. Am J Clin Nutr 2001, 73: 1019-26.
74. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999, 131: 281-303.
75. Maher RJ, Adler ML. Clinical Review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology and treatment. J Clin Endocrinol Metab 1999, 84: 1165-70.
76. Jones LK, Arslanian S, Peterokova V, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 2002, 25: 89-94.
77. Dean HJ, Young TK, Flett B, Wood-Steiman P. Screening for type 2 diabetes in aboriginal children in northern Canada. Lancet 1998, 352: 1523-4.
78. US Food and Drug Administration, Center for Drug Evaluation and Research. BPCA/pediatric exclusivity statistics. Summaries of medical and clinical pharmacology reviews. Available from http://www. Fda.gov/cder/pediatric/ Summaryreview.htm. Accessed February 4, 2004.
79. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 2003, 26: 2194-7.